Tetanus toxin L chain is processed by major histocompatibility complex class I and class II pathways and recognized by CD8+ or CD4+ T lymphocytes

Immunology

Volumn 100, Issue 2, 2000, Pages 178-184

  Kerblat, I ^a,b   Tongiani Dahshan, S ^a   Aude Garcia, C ^a   Villiers, M B ^a   Drouet, C ^a,c   Marche, P N ^a  

^a INSERM   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CD4 ANTIGEN; CD8 ANTIGEN; CHLOROQUINE; EPITOPE; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; LACTACYSTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEASOME INHIBITOR; TETANUS TOXIN; ZINC;

ANTIBIOTIC SENSITIVITY; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL SEPARATION; CELL STRAIN U937; CELLULAR DISTRIBUTION; CENTRIFUGATION; CONTROLLED STUDY; CYTOSOL; DRUG RESISTANCE; ENDOCYTOSIS; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYSOSOME; PRIORITY JOURNAL; PROTEINASE INHIBITION; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; ANTIGENS, BACTERIAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CLOSTRIDIUM TETANI; CYTOSOL; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; TETANUS TOXIN; TUMOR CELLS, CULTURED; ZINC;

EID: 0034039368     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00032.x     Document Type: Article

References (40)

1. 1. EISEL U., JARAUSCH W., GORETZKI K. et al. (1986) Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J 5, 2495.
2. 2. FAIRWEATHER N.F. & LYNESS V.A. (1986) The complete nucleotide sequence of tetanus toxin. Nucl Acid Res 14, 7809.
3. 3. WRIGHT J.F., PERNOLLET M., REBOUL A., AUDE C. & COLOMB M.G. (1992) Identification and partial characterization of a low affinity metal site in the light chain of tetanus toxin. J Biol Chem 267, 9053.
4. 4. MOCHIDA S., POULAIN B., EISEL U. et al. (1990) Exogenous mRNA encoding tetanus or botulinum neurotoxins expressed in Aplysia neurons. Proc Natl Acad Sci USA 87, 7844.
5. 5. SCHIAVO G., POULAIN B., ROSSEIO O., BENFENATI F., TAUC L. & MONTECUCCO C. (1992) Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J 11, 3577.
6. 6. SCHIAVO G., BENFENATI F., POULAIN B. et al. (1992) Tetanus and botulinum -B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832.
7. 7. MCMAHON H.T., USHKARYOV Y.A., EDELMANN L. et al. (1993) Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature 364, 346.
8. 8. JACQUIER SARLIN M.R., GABERT F.M., VILLIERS M.-B. & COLOMB M.G. (1995) Modulation of antigen processing and presentation by covalently linked complement C3b fragment. Immunology 84, 164.
9. 9. SERRA V.A., CRETIN F., PÉPIN E., GABERI F.M. & MARCHE P.N. (1997) Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer production. Eur J Immunol 27, 2673.
10. 10. VILLIERS M.-B., GABERT F.M., JACQUIER M.R., VILLIERS C.L. & COLOMB M.G. (1993) Involvement of the Zn-binding region of tetanus toxin in B and T recognition. Influence of Zn fixation. Mol Immunol 30, 129.
11. 11. CORRADIN G. & WATTS C. (1995) Cellular immunology of tetanus toxoid. Curr Top Microbiol Immunol 195, 77.
12. 12. DEMOTZ S., LANZAVECCHIA A., EISEL U., NIFMANN H., WIDMANN C. & CORRADIN G. (1989) Delineation of several DR-restricted tetanus toxin T cell epitopes. J Immunol 142, 394.
13. 13. PANINA-BORDIGNON P., TAN A., TERMIJTELEN A., DEMOTZ S., CORRADIN G. & LANZAVECCHIA A. (1989) Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 19, 2237.
14. 14. REECE J.C., GEYSEN H.M. & RODDA S.J. (1993) Mapping the major human T cell epitopes of tetanus toxin. The emerging picture. J Immunol 151, 6175.
15. + lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences. J Autoimmun 9, 79.
16. 16. VILLIERS M.-B., VILLIERS C.L., WRIGHT J.F., MAISON C.M. & COLOMB M.G. (1991) Formation of covalent C3b-tetanus toxin complexes: a tool for in vitro study of antigen presentation. Scand J Immunol 34, 585.
17. 17. MATSUDA M. & YONEDA M. (1975) Isolation and purification of two antigenically active, 'complementary' polypeptide fragments of tetanus neurotoxin. Infect Immun 12, 1147.
18. 18. FAIRWEATHER N.F., SANDERS D., SLATER D., HUDEL M., HABERMANN E. & WEILER U. (1993) Production of biologically active light chain of tetanus toxin in Escherichia coli. Evidence for the importance of the C-terminal 16 amino acids for full biological activity. FEBS Lett 323, 218.
19. 19. EDELHOCH H. (1967) Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6, 1948.
20. 20. SALACINSKI P.R.P., MCLEAN C., SYKES J.E.C., CLEMENT-JONES V.V. & LOWRY P.J. (1981) Iodination of proteins, glycoproteins and peptides using a solid-phase oxidizing agent, 1, 3, 4, 6-tetrachloro-3α, 6α diphenyl glycoluril (Iodogen). Anal Biochem 117, 136.
21. 21. PENEESKY H.S. (1977) Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. J Biol Chem 252, 2891.
22. 22. AMAN P., EHLIN-HENRICKSSON B. & KLEIN G. (1984) Epstein-Barr virus susceptibility of normal B lymphocytes populations. J Exp Med 159, 208.
23. 23. SANTORO L., DROUET C., REBOUL A., MACH J.-P. & COLOMB M.G. (1994) Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells. Eur J Immunol 24, 1620.
24. 24. DARTE A.E. & BEAUFAY H. (1983) Analytical subcellular fractionation of cultivated mouse resident peritoneal macrophages. J Exp Med 157, 1208.
25. 25. LAEMMLI U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680.
26. 26. CRAIU A., GACZYNSKA M., AKOPIAN T. et al. (1997) Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem 272, 13437.
27. 27. LEE D.H. & GOLDBERG A.L. (1998) Proteasome inhibitors: valuable tools for cell biologists. Trends Cell Biol 8, 397.
28. 28. REBOUL A., ARVIEUX J., WRIGHT J.F. & COLOMB M.G. (1991) Proteolytic fragmentation of tetanus toxin by subcellular fractions of JY, a B lymphoblastoid cell line. Biochem J 277, 47.
29. 29. BEVAN M.J. (1987) Class discrimination in the world of immunology. Nature 325, 192.
30. 30. REIS E SOUSA C. & GERMAIN R.N. (1995) Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 182, 841.
31. 31. HARDING C.V. (1995) Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol 5, 105.
32. 32. ROCK K.L. (1996) A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today 17, 131.
33. 33. GUERMONPREZ P., LADANT D., KARIMOVA G., ULLMANN A. & LECLERC C. (1999) Direct delivery of the Bordetella pertussis adenylate cyclase toxin to the MHC class I antigen presentation pathway. J Immunol 162, 1910.
34. 34. PINET V., MALNATI M.S. & LONG E.O. (1994) Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol 152, 4852.
35. 35. GRIFFIN J.P., CHU R. & HARDING C.V. (1997) Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J Immunol 158, 1523.
36. 36. PAPINI E., RAPPUOLI R., MURGIA M. & MONTECUCCO C. (1993) Cell penetration of diphtheria toxin. Reduction of the interchain disulfide bridge is the rate-limiting step of translocation in the cytosol. J Biol Chem 268, 1567.
37. 37. SAELINGER C.B. & MORRIS R.E. (1994) Uptake and processing of toxins by mammalian cells. Meth Enzymol 235, 705.
38. 38. MATTEOLI M., VERDERIO C., ROSSETO O. et al. (1996) Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc Natl Acad Sci USA 93, 13310.
39. 39. DEMOTZ S., BARBEY C., CORRADIN G., AMOROSO A. & LANZAVECCHIA A. (1993) The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur J Immunol 23, 425.
40. 40. KE Y., LI Y. & KAPP J.A. (1997) Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur J Immunol 25, 549.